Clinical Trial Update: Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients [NA]

View source ↗

Summary

An update on a trial evaluating the safety and efficacy of a raltegravir-based regimen (raltegravir + tenofovir disoproxil fumarate + lamivudine) in patients co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Epivir (Lamivudine)
• Isentress (Raltegravir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yunnan AIDS Care Center | Conditions: HBV Coinfection, HIV Infections | NA | Status: UNKNOWN